Heron Therapeutics, Inc. HRTX
$0.49
+5.81%
at last close
Market Cap$91.97 million
P/E Ratio—
Div Yield—
Volume1.68M
52-Week Range
$0.38$2.30
Key Stats
- Today's Range
- $0.45 – $0.50
- 50-Day Range
- $0.38 – $0.93
- 52-Week Range
- $0.38 – $2.30
- Volume
- 1.68 million shs
- Average Volume
- 3.04 million shs
- Market Cap
- $91.97 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 3.93%
- Days to Cover
- 6.54
About Heron Therapeutics, Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.